ImmunoSensation - the immune sensory system

26. Quantifying the Severity of Parkinson Disease by Use of Dopaminergic Neuroimaging.
Takahashi H, Watanabe Y, Tanaka H, Mochizuki H, Kato H, Hatazawa J, Tomiyama N
AJR Am J Roentgenol. 2019 Apr 17.
PMID: 30995093
27. Vancomycin ocular delivery systems based on glycerol monooleate reversed hexagonal and reversed cubic liquid crystalline phases.
Milak S, Chemelli A, Glatter O, Zimmer A
Eur J Pharm Biopharm. 2019 Apr 16.
PMID: 31002864
28. CDK12 loss in cancer cells affects DNA damage response genes through premature cleavage and polyadenylation.
Krajewska M, Dries R, Grassetti AV, Dust S, Gao Y, Huang H, Sharma B, Day DS, Kwiatkowski N, Pomaville M, Dodd O, Chipumuro E, Zhang T, Greenleaf AL, Yuan GC, Gray NS, Young RA, Geyer M, Gerber SA, George RE
Nat Commun. 2019 Apr 15.
PMID: 30988284
29. cGMP manipulation in cardiometabolic disease: chances and challenges.
Jordan J, Hildebrand S, Pfeifer A
Curr Opin Cardiol. 2019 Apr 15.
PMID: 30994530
30. Enzymatic Activity of HPGD in Treg Cells Suppresses Tconv Cells to Maintain Adipose Tissue Homeostasis and Prevent Metabolic Dysfunction.
Schmidleithner L, Thabet Y, Schönfeld E, Köhne M, Sommer D, Abdullah Z, Sadlon T, Osei-Sarpong C, Subbaramaiah K, Copperi F, Haendler K, Varga T, Schanz O, Bourry S, Bassler K, Krebs W, Peters AE, Baumgart AK, Schneeweiss M, Klee K, Schmidt SV, Nüssing S, Sander J, Ohkura N, Waha A, Sparwasser T, Wunderlich FT, Förster I, Ulas T, Weighardt H, Sakaguchi S, Pfeifer A, Blüher M, Dannenberg AJ, Ferreirós N, Muglia LJ, Wickenhauser C, Barry SC, Schultze JL, Beyer M
Immunity. 2019 Apr 15.
PMID: 31027998
31. Oligomeric S100A4 Is Associated With Monocyte Innate Immune Memory and Bypass of Tolerance to Subsequent Stimulation With Lipopolysaccharides.
Neidhart M, Pajak A, Laskari K, Riksen NP, Joosten LAB, Netea MG, Lutgens E, Stroes ESG, Ciurea A, Distler O, Grigorian M, Karouzakis E
Front Immunol. 2019 Apr 15.
PMID: 31037071
32. HIF1A and NFAT5 coordinate Na-boosted antibacterial defense via enhanced autophagy and autolysosomal targeting.
Neubert P, Weichselbaum A, Reitinger C, Schatz V, Schröder A, Ferdinand JR, Simon M, Bär AL, Brochhausen C, Gerlach RG, Tomiuk S, Hammer K, Wagner S, van Zandbergen G, Binger KJ, Müller DN, Kitada K, Clatworthy MR, Kurts C, Titze J, Abdullah Z, Jantsch J
Autophagy. 2019 Apr 14.
PMID: 30982460
33. Benefits of a factorial design focusing on inclusion of female and male animals in one experiment.
Buch T, Moos K, Ferreira FM, Fröhlich H, Gebhard C, Tresch A
J Mol Med (Berl). 2019 Apr 13.
PMID: 30980104
34. Mutation in the mouse histone gene Hist2h3c1 leads to degeneration of the lens vesicle and severe microphthalmia.
Vetrivel S, Tiso N, Kügler A, Irmler M, Horsch M, Beckers J, Hladik D, Giesert F, Gailus-Durner V, Fuchs H, Sabrautzki S, , Adler T, Treise I, Busch DH, Aguilar-Pimentel A, Ollert M, Götz A, Amarie OV, Stoeger T, Schulz H, Becker L, Klopstock T, Schrewe A, Spielmann N, Bekeredjian R, Garrett L, Hölter SM, Zimprich A, Wurst W, Mayer-Kuckuk P, Hans W, Rozman J, Klingenspor M, Neff F, da Silva-Buttkus P, Calzada-Wack J, Rácz I, Zimmer A, Rathkolb B, Wolf E, Prehn C, Adamski J, Östereicher M, Miller G, Steinkamp R, Lengger C, Maier H, Stoeger C, Leuchtenberger S, Gailus-Durner V, Fuchs H, Hrabě de Angelis M, Hrabě de Angelis M, Graw J
Exp Eye Res. 2019 Apr 13.
PMID: 30991053
35. Membrane fusogenic lysine type lipid assemblies possess enhanced NLRP3 inflammasome activation potency.
He J, Li T, Próchnicki T, Horvath G, Latz E, Takeoka S
Biochem Biophys Rep. 2019 Apr 12.
PMID: 31011633
36. Update on the biology and ecology of Culicoides species in the South-West region of Cameroon with implications on the transmission of Mansonella perstans.
Wanji S, Tayong DB, Ebai R, Opoku V, Kien CA, Ndongmo WPC, Njouendou AJ, Ghani RN, Ritter M, Debrah YA, Layland LE, Enyong PA, Hoerauf A
Parasit Vectors. 2019 Apr 11.
PMID: 30975194
37. Impact of Hemodynamic Support on Outcome in Patients Undergoing High-Risk Percutaneous Coronary Intervention.
Shamekhi J, Pütz A, Zimmer S, Tiyerili V, Mellert F, Welz A, Fimmers R, Grube E, Nickenig G, Werner N, Sinning JM
Am J Cardiol. 2019 Apr 10.
PMID: 31056109
38. Therapeutic targeting of trained immunity.
Mulder WJM, Ochando J, Joosten LAB, Fayad ZA, Netea MG
Nat Rev Drug Discov. 2019 Apr 9.
PMID: 30967658
39. Health-related quality-of-life and treatment satisfaction of individuals with hemophilia A treated with turoctocog alfa pegol (N8-GP): a new recombinant extended half-life FVIII.
Kearney S, Raffini LJ, Pham TP, Lee XY, von Mackensen S, Landorph A, Takedani H, Oldenburg J
Patient Prefer Adherence. 2019 Apr 9.
PMID: 31040652
40. Early clearance of Mycobacterium tuberculosis is associated with increased innate immune responses.
Verrall AJ, Schneider M, Alisjahbana B, Apriani L, van Laarhoven A, Koeken VACM, van Dorp S, Diadani E, Utama F, Hannaway RF, Indrati A, Netea MG, Sharples K, Hill PC, Ussher JE, van Crevel R
J Infect Dis. 2019 Apr 8.
PMID: 30958547
41. Current understanding of fear learning and memory in humans and animal models and the value of a linguistic approach for analyzing fear learning and memory in humans.
Raber J, Arzy S, Bertolus JB, Depue B, Haas HE, Kangas M, Kensinger E, Lowry CA, Marusak HA, Minnier J, Mouly AM, Muehlberger A, Norrholm SD, Peltonen K, Pinna G, Rabinak C, Shiban Y, Soreq H, van der Kooij MA, Lowe L, Weingast LT, Yamashita P, Boutros SW
Neurosci Biobehav Rev. 2019 Apr 7.
PMID: 30970272
42. Detailed methylation map of LINE-1 5'-promoter region reveals hypomethylated CpG hotspots associated with tumor tissue specificity.
Sharma A, Jamil MA, Nuesgen N, Dauksa A, Gulbinas A, Schulz WA, Oldenburg J, El-Maarri O
Mol Genet Genomic Med. 2019 Apr 6.
PMID: 30955237
43. Current status and future perspective of structural heart disease intervention.
Tabata N, Sinning JM, Kaikita K, Tsujita K, Nickenig G, Werner N
J Cardiol. 2019 Apr 5.
PMID: 30955999
44. The Effect of Non-Gabapentinoid Anticonvulsants on Sensorimotor Recovery After Human Spinal Cord Injury.
Warner FM, Jutzeler CR, Cragg JJ, Tong B, Grassner L, Bradke F, Geisler F, Kramer JK
CNS Drugs. 2019 Apr 4.
PMID: 30949923
45. Correction to: Identification of novel mutations in congenital afibrinogenemia patients and molecular modeling of missense mutations in Pakistani population.
Naz A, Biswas A, Khan TN, Goodeve A, Ahmed N, Saqlain N, Ahmed S, Ujjan ID, Shamsi TS, Oldenburg J
Thromb J. 2019 Apr 4.
PMID: 30988665
46. Sodium thiocyanate treatment attenuates atherosclerotic plaque formation and improves endothelial regeneration in mice.
Zietzer A, Niepmann ST, Camara B, Lenart MA, Jansen F, Becher MU, Andrié R, Nickenig G, Tiyerili V
PLoS One. 2019 Apr 2.
PMID: 30939159
47. Editorial: shining a light on cholangiocarcinoma-a new dawn for photodynamic therapy? Authors' reply.
Gonzalez-Carmona MA, Bolch M, Strassburg CP, Weismüller TJ
Aliment Pharmacol Ther. 2019 Apr 1.
PMID: 30868630
48. Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology.
Boersma LV, Ince H, Kische S, Pokushalov E, Schmitz T, Schmidt B, Gori T, Meincke F, Protopopov AV, Betts T, Mazzone P, Foley D, Grygier M, Sievert H, De Potter T, Vireca E, Stein K, Bergmann MW,
Circ Arrhythm Electrophysiol. 2019 Apr 1.
PMID: 30939908
49. Pathophysiology of atopic dermatitis.
Grobe W, Bieber T, Novak N
J Dtsch Dermatol Ges. 2019 Apr 1.
PMID: 30958934
50. Pathophysiologie der atopischen Dermatitis.
Grobe W, Bieber T, Novak N
J Dtsch Dermatol Ges. 2019 Apr 1.
PMID: 30958929